Literature DB >> 10483012

The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE.

D A Whitelaw1, J J Spangenberg, R Rickman, F H Hugo, M Roberts.   

Abstract

OBJECTIVE: To examine the relationship between neuropsychological impairment and antiphospholipid antibody syndrome (aPL syndrome) in patients with systemic lupus erythermatosus (SLE). PATIENTS: Sixty-nine patients satisfying ACR criteria were studied. Sixteen patients with the aPL syndrome and 53 patients without the syndrome were subjected to eight neuropsychological tests, a physical examination and serological investigations. No patients with other pathology, known to cause acute or chronic impairment of neuropsychological function, were included. Sixty-five underwent MRI scans.
RESULTS: There were no significant differences in age, level of education, incidence of hypertension or disease activity in the two groups. Pearson's correlation coefficients revealed a significant negative correlation with duration of disease in six out of eight tests in the aPL positive group and one out of eight in the aPL negative group. This suggests that aPL syndrome may be involved in the psychological impairment in SLE patients. A larger cohort needs to be studied to confirm this observation.

Entities:  

Mesh:

Year:  1999        PMID: 10483012     DOI: 10.1177/096120339900800606

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  5 in total

1.  Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.

Authors:  L Barile-Fabris; R Ariza-Andraca; L Olguín-Ortega; L J Jara; A Fraga-Mouret; J M Miranda-Limón; J Fuentes de la Mata; P Clark; F Vargas; J Alocer-Varela
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

Review 2.  Biomarkers for CNS involvement in pediatric lupus.

Authors:  Tamar B Rubinstein; Chaim Putterman; Beatrice Goilav
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

3.  Survival of patients with SLE admitted to an intensive care unit-a retrospective study.

Authors:  D A Whitelaw; R Gopal; V Freeman
Journal:  Clin Rheumatol       Date:  2004-11-25       Impact factor: 2.980

4.  Pregnancy in systemic lupus erythematosus: a retrospective study from a developing community.

Authors:  D A Whitelaw; D Hall; T Kotze
Journal:  Clin Rheumatol       Date:  2007-10-02       Impact factor: 2.980

5.  Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review.

Authors:  Claire Donnellan; Hannah Cohen; David J Werring
Journal:  Rheumatology (Oxford)       Date:  2021-12-24       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.